Ozempic and GLP-1 Drugs: Risks, Trends, and Effectiveness in Weight Loss

Ozempic, a popular drug for weight loss and diabetes, is facing numerous lawsuits due to alleged severe side effects, especially irreversible vision loss from NAION, with regulatory bodies and studies supporting a potential link. The legal battle is intensifying, with significant financial and reputational risks for Novo Nordisk, as plaintiffs share personal stories and courts consider the evidence. The outcome could reshape pharmaceutical accountability and drug safety standards.